Trask Adam Roland’s VanEck Pharmaceutical ETF PPH Stock Holding History

Trask Adam Roland’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.6K	Buy	+400	New	+$42.6K	0.04%	115

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Trask Adam Roland's PPH Position: Q1 2026 in Review

Trask Adam Roland opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2026: 400 shares worth $41.6K. The stake represents 0.04% of the portfolio and ranks #115 among its holdings.

147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Trask Adam Roland held 400 shares of VanEck Pharmaceutical ETF worth $41.6K as of Q1 2026.
VanEck Pharmaceutical ETF was a new Trask Adam Roland position in Q1 2026.
VanEck Pharmaceutical ETF made up 0.04% of Trask Adam Roland's portfolio in Q1 2026, its #115 holding.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Trask Adam Roland's 13F filing for Q1 2026, filed 15 May 2026.